Terumo Corporation
FDA 510(k) & PMA Approved Devices — 9 products
Total Devices9
Categories6
Latest FDA decision2026-03-27
| Type | Number | Device Name | Code | Date | Actions |
|---|---|---|---|---|---|
| 510(k) | K252295 | Ryurei | LOX | 2026-03-27 | View |
| 510(k) | K250700 | Pen Injector Needle 32.5 | FMI | 2025-11-21 | View |
| 510(k) | K250751 | DualView Catheter | DQO | 2025-07-17 | View |
| 510(k) | K240818 | R2P Radifocus Glidewire Advantage | DQX | 2024-11-26 | View |
| 510(k) | K240859 | Glidewire GT-R | DQX | 2024-08-21 | View |
| 510(k) | K190427 | Immucise | FMF | 2019-07-18 | View |
| 510(k) | K181369 | Immucise Intradermal Injection System | FMI | 2018-11-13 | View |
| 510(k) | K173799 | NaviCross 0.018 | DQY | 2018-03-29 | View |
| 510(k) | K170417 | Glidewire GT | DQX | 2017-09-15 | View |
No matching devices.
Related Clinical Trials
NCT01524211Evaluation of Branch Endografts in the Treatment of Aortic AneurysmsRECRUITINGNCT04503395ShOrt neCK AAA RAndomized Trial - ESAR and FEVAR: SOCRATESRECRUITINGNCT04545502PANTHER Study of Terumo Aortic Knitted and Woven Grafts, and Cardiovascular PatchesRECRUITINGNCT05650411Ultrathin-strut Biodegradable Polymer Sirolimus-eluting Stents With P2Y12 Inhibitor-based Single Antiplatelet Therapy vs. Conventional DAPT for Unprotected Left Main Coronary Artery Disease (ULTIMATE-LM)RECRUITINGNCT07218406Comparison of Merit Prelude Ideal and Terumo Glidesheath Slender Radial Artery SheathsCOMPLETEDNCT07611968Prospective Evaluation of Physician Modified Endografts for Aortic DiseaseRECRUITINGNCT07633561Feasibility and Clinical Utility of Ambulatory Ultraslow Deflation Sphygmomanometers in LVAD Recipients - easiSLOW-LVAD PilotNOT_YET_RECRUITINGNCT07761598The TERUMO FRED X EARLY FEASIBILITY STUDY (FAST) STUDY.NOT_YET_RECRUITING